Publication: Phikud Navakot Modulates the Level of Pro-Inflammatory Mediators and the Protein Expression of SOD1 and 2 and the Nrf2/HO-1 Signaling Pathway in Rats with Acute Myocardial Infarction
| dc.contributor.author | Gerdprasert O. | |
| dc.contributor.author | Choomchuay N. | |
| dc.contributor.author | Chantong B. | |
| dc.contributor.author | Sutanthavibul N. | |
| dc.contributor.author | Meksuriyen D. | |
| dc.contributor.author | Nusuetrong P. | |
| dc.date.accessioned | 2021-04-05T03:04:23Z | |
| dc.date.available | 2021-04-05T03:04:23Z | |
| dc.date.issued | 2019 | |
| dc.date.issuedBE | 2562 | |
| dc.description.abstract | Phikud Navakot (PN) is nine major herbs in a famous traditional Thai recipe namely "Yahom Navakot" used to treat cardiovascular disorders. This study investigated the cardioprotective effects of PN formula on isoproterenol-induced myocardial infarction (IMI) in Sprague-Dawley rats. Forty-five rats were randomly divided into nine groups (n = 5 per group): the control, the IMI, the IMI + propranolol, the control or the IMI + PN formula (PN ethanolic extract at doses of 64, 127, or 255 mg/kg) by oroesophageal gavage for 28 days. The ST segment and serum troponin T levels were significantly increased in IMI rats. PN did not eliminate tissue necrosis, infiltration of inflammatory cells, or interstitial edema in IMI rats. All doses of PN decreased (p<0.001) serum TNF-α and IL-6 levels. PN (127 and 255 mg/kg) up-regulated (p<0.05) heme oxygenase (HO)-1 expression, whereas PN (255 mg/kg) significantly increased superoxide dismutase (SOD) 1 and 2 expression, compared with IMI rats. Nuclear factor erythroid 2-related factor 2 (Nrf2) and HO-1 expression significantly increased in IMI rats and IMI rats that received PN. PN formula possesses potential anti-inflammatory and antioxidant properties by modulating the levels of TNF-α, IL-6 and antioxidant enzymes. Our study reveals a novel cardioprotective effect of PN in IMI rats through the Nrf2/HO-1 signaling. © 2019 Orapin Gerdprasert et al. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Evidence-based Complementary and Alternative Medicine. Vol 2019, (2019) | |
| dc.identifier.doi | 10.1155/2019/4823645 | |
| dc.identifier.issn | 1741427X | |
| dc.identifier.other | 2-s2.0-85073078632 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/5620 | |
| dc.rights.holder | มหาวิทยาลัยศรีนครินทรวิโรฒ | |
| dc.subject.other | Alcohol | |
| dc.subject.other | Antiinflammatory agent | |
| dc.subject.other | Antioxidant | |
| dc.subject.other | Cardiovascular agent | |
| dc.subject.other | Catalase | |
| dc.subject.other | Copper zinc superoxide dismutase | |
| dc.subject.other | Glutathione peroxidase | |
| dc.subject.other | Heme oxygenase 1 | |
| dc.subject.other | Herbaceous agent | |
| dc.subject.other | Interleukin 6 | |
| dc.subject.other | Manganese superoxide dismutase | |
| dc.subject.other | Phikud navakot | |
| dc.subject.other | Propranolol | |
| dc.subject.other | Protective agent | |
| dc.subject.other | Transcription factor Nrf2 | |
| dc.subject.other | Troponin T | |
| dc.subject.other | Tumor necrosis factor | |
| dc.subject.other | Unclassified drug | |
| dc.subject.other | Acute heart infarction | |
| dc.subject.other | Animal experiment | |
| dc.subject.other | Animal model | |
| dc.subject.other | Animal tissue | |
| dc.subject.other | Antiinflammatory activity | |
| dc.subject.other | Antioxidant activity | |
| dc.subject.other | Article | |
| dc.subject.other | Cell infiltration | |
| dc.subject.other | Controlled study | |
| dc.subject.other | Cytokine release | |
| dc.subject.other | Drug dose comparison | |
| dc.subject.other | Drug efficacy | |
| dc.subject.other | Drug mechanism | |
| dc.subject.other | Edema | |
| dc.subject.other | Enzyme activity | |
| dc.subject.other | Ethnopharmacology | |
| dc.subject.other | Heart muscle injury | |
| dc.subject.other | Heart muscle necrosis | |
| dc.subject.other | Heart protection | |
| dc.subject.other | Heart tissue | |
| dc.subject.other | Inflammation | |
| dc.subject.other | Inflammatory cell | |
| dc.subject.other | Inflammatory infiltrate | |
| dc.subject.other | Interstitial edema | |
| dc.subject.other | Isoproterenol-induced myocardial infarction | |
| dc.subject.other | Male | |
| dc.subject.other | Mediator release | |
| dc.subject.other | Nonhuman | |
| dc.subject.other | Oxidative stress | |
| dc.subject.other | Protein blood level | |
| dc.subject.other | Protein expression | |
| dc.subject.other | Rat | |
| dc.subject.other | Signal transduction | |
| dc.subject.other | ST segment | |
| dc.subject.other | Tissue necrosis | |
| dc.subject.other | Upregulation | |
| dc.title | Phikud Navakot Modulates the Level of Pro-Inflammatory Mediators and the Protein Expression of SOD1 and 2 and the Nrf2/HO-1 Signaling Pathway in Rats with Acute Myocardial Infarction | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073078632&doi=10.1155%2f2019%2f4823645&partnerID=40&md5=a21832711209112cb0d6f5353f0ff099 |
